Allied Healthcare Products
AHPI
AHPI was delisted on the 2nd of February, 2023.
19 hedge funds and large institutions have $5.95M invested in Allied Healthcare Products in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
6% more funds holding
Funds holding: 18 → 19 (+1)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
0.41% less ownership
Funds ownership: 13.01% → 12.6% (-0.41%)
35% less capital inflows, than outflows
Capital inflows: $957K | Capital outflows: $1.47M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$233K |
| 2 |
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
+$172K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$156K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$144K |
| 5 |
BlackRock
New York
|
+$88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$357K |
| 2 |
MYDA Advisors
Woodmere,
New York
|
-$350K |
| 3 |
Bridgeway Capital Management
Houston,
Texas
|
-$291K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$280K |
| 5 |
Renaissance Technologies
New York
|
-$159K |
AHPI Hedge Fund Activity: Q2 2020 in Review
19 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q2 2020, worth a combined $5.95M — down 35% from $9.14M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AHPI positions and 4 closed out — a net gain of 1 holder — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Barclays, opening a new position worth an estimated $233K. The largest seller was Jane Street, exiting entirely with an estimated $357K sold.
- 19 institutional investors held Allied Healthcare Products (AHPI) as of Q2 2020, up from 18 in Q1 2020.
- Funds reported $5.95M of Allied Healthcare Products stock for Q2 2020, down 35% quarter-over-quarter.
- 5 funds opened new Allied Healthcare Products positions in Q2 2020 and 4 closed out, a net change of +1 holder.
- The largest Allied Healthcare Products buyer in Q2 2020 was Barclays, an estimated $233K added.
- The largest Allied Healthcare Products seller in Q2 2020 was Jane Street, an estimated $357K sold.
Based on aggregated 13F filings for Q2 2020.